Urocortin: A biomarker deserving investigation for endometriosis patients
Urocortin may be a potentially useful tool for the classification of endometriosis regarding its correlation with the severity of the disease.
Key Points Lay Summary
The coelomic metaplasia hypothesis of endometriosis in MRKH cases
The development of endometriosis in patients with MRKH could be explained through implantation hypothesis from uterus/endometrium remnants and coelomic metaplasia hypothesis.
Key Points Lay Summary
ENDORECT scoring system to identify patients at risk for rectosigmoid endometriosis
ENDORECT: Can a pre-operative score effectively predict rectosigmoid involvement in patients with endometriosis?
Key Points Lay Summary
Endometriosis pathophysiology: research in genes updated
What are the promising genetic research methods in endometriosis ?
Key Points Lay Summary
Novel inhibitors of estrogen biosynthesis
Dr. Ferrero group suggest that the generation of inhibitors blocking the local estrogen biosynthesis is the future direction in endometriosis treatment
Key Points Lay Summary
Another Genetic Polymorphism That May Increase Risk of Endo
A single letter change in the gene encoding a protein that controls cell proliferation can significantly increase endometriosis risk, at least in Chinese women.
Key Points Lay Summary
Searching new biomarkers for endometriosis
The lack of a biomarker in endometriosis is due to the heterogeneous nature of this disease.
Key Points Lay Summary
Could a defect in phagocytosis cause endometriosis?
The macrophages are important immune cells in the peritoneal cavity because they function to remove aberrant cells or tissues by the process of phagocytosis.
Key Points Lay Summary